Claymore launches ETFs

Claymore Securities Inc. has launched two exchange traded funds on the American Stock Exchange today, themed on brokerages to vaccines. The Lisle, Ill.-based investment boutique has teamed up with Clear Indexes LLC to launch the Global Exchanges, Brokers & Asset Managers Index, and the Global Vaccine Index exchange-traded funds. The Global Exchanges, Brokers & Asset Managers Index, which trades under the "EXB" ticker symbol, is made up of approximately 100 equity securities traded on global exchanges, American depositary receipts and global depositary receipts of companies that operate a security exchange or brokerage/asset management firm as a primary business. The Global Vaccine Index, which trades under the "JNR" ticker symbol, seeks to track the Clear Global Vaccine Index. The Index is made up of 40 securities traded on developed market exchanges as well as ADRs and GDRs of companies that research, develop, manufacture, license, and/or market vaccines. Clear Indexes is a New York-based developer of custom indices. Each fund carries an expense ratio of 0.65%. Claymore also launched the Robeco Boston Partners Large-Cap Value ETF today, which tracks an index designed to identify a group of stocks that display characteristics that give them the potential to outperform other large-cap value indices, while maintaining strong risk diversification. The fund, which trades under the "CLV" ticker symbol, seeks investment results that correspond generally to the performance of the Robeco Boston Partners Large Cap Value Index. Claymore Securities Inc. managed $17 billion in assets as of May 31.